80 related articles for article (PubMed ID: 21320776)
1. Synthesis and SAR of sulfoxide substituted carboxyquinolines as NK3 receptor antagonists.
Xiong H; Kang J; Woods JM; McCauley JP; Koether GM; Albert JS; Hinkley L; Li Y; Gadient RA; Simpson TR
Bioorg Med Chem Lett; 2011 Mar; 21(6):1896-9. PubMed ID: 21320776
[TBL] [Abstract][Full Text] [Related]
2. N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists.
Elliott JM; Carling RW; Chambers M; Chicchi GG; Hutson PH; Jones AB; MacLeod A; Marwood R; Meneses-Lorente G; Mezzogori E; Murray F; Rigby M; Royo I; Russell MG; Sohal B; Tsao KL; Williams B
Bioorg Med Chem Lett; 2006 Nov; 16(22):5748-51. PubMed ID: 16950620
[TBL] [Abstract][Full Text] [Related]
3. New quinoline NK3 receptor antagonists with CNS activity.
Smith PW; Wyman PA; Lovell P; Goodacre C; Serafinowska HT; Vong A; Harrington F; Flynn S; Bradley DM; Porter R; Coggon S; Murkitt G; Searle K; Thomas DR; Watson JM; Martin W; Wu Z; Dawson LA
Bioorg Med Chem Lett; 2009 Feb; 19(3):837-40. PubMed ID: 19117759
[TBL] [Abstract][Full Text] [Related]
4. N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II.
Elliott JM; Carling RW; Chicchi GG; Crawforth J; Hutson PH; Jones AB; Kelly S; Marwood R; Meneses-Lorente G; Mezzogori E; Murray F; Rigby M; Royo I; Russell MG; Shaw D; Sohal B; Tsao KL; Williams B
Bioorg Med Chem Lett; 2006 Nov; 16(22):5752-6. PubMed ID: 16950617
[TBL] [Abstract][Full Text] [Related]
5. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
6. Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor.
Geldenhuys WJ; Kuzenko SR; Simmons MA
J Med Chem; 2010 Nov; 53(22):8080-8. PubMed ID: 21047106
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).
Giardina GA; Raveglia LF; Grugni M; Sarau HM; Farina C; Medhurst AD; Graziani D; Schmidt DB; Rigolio R; Luttmann M; Cavagnera S; Foley JJ; Vecchietti V; Hay DW
J Med Chem; 1999 Mar; 42(6):1053-65. PubMed ID: 10090788
[TBL] [Abstract][Full Text] [Related]
8. Identification of a new series of non-peptidic NK3 receptor antagonists.
Juhl K; Hansen T; Kehler J; Khanzhin NA; Nørgaard MB; Ruhland T; Larsen DB; Jensen KG; Steiniger-Brach B; Nielsen SM; Simonsen KB
Bioorg Med Chem Lett; 2011 Mar; 21(5):1498-501. PubMed ID: 21292483
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of potential dual NK(1)/NK(3) receptor antagonists.
Hanessian S; Babonneau V; Boyer N; Mannoury la Cour C; Millan MJ; De Nanteuil G
Bioorg Med Chem Lett; 2014 Jan; 24(2):510-4. PubMed ID: 24374277
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 2-(4-biphenylyl)quinoline-4-carboxylate and carboxamide analogs. New human neurokinin-3 (hNK-3) receptor antagonists.
Saudi MN; Rostom SA; Fahmy HT; El Ashmawy IM
Arch Pharm (Weinheim); 2003 Jun; 336(3):165-74. PubMed ID: 12822182
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potent, balanced and orally active dual NK1/NK3 receptor ligands.
Peters JU; Hoffmann T; Schnider P; Stadler H; Koblet A; Alker A; Poli SM; Ballard TM; Spooren W; Steward L; Sleight AJ
Bioorg Med Chem Lett; 2010 Jun; 20(11):3405-8. PubMed ID: 20430616
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel NK1/NK3 dual antagonists for the potential treatment of schizophrenia.
Catalani MP; Alvaro G; Bernasconi G; Bettini E; Bromidge SM; Heer J; Tedesco G; Tommasi S
Bioorg Med Chem Lett; 2011 Nov; 21(22):6899-904. PubMed ID: 21974957
[TBL] [Abstract][Full Text] [Related]
13. Rational design of novel pyrrolidine derivatives as orally active neurokinin-3 receptor antagonists.
Ratni H; Ballard TM; Bissantz C; Hoffmann T; Jablonski P; Knoflach F; Knust H; Malherbe P; Nettekoven M; Patiny-Adam A; Riemer C; Schmitt M; Spooren W
Bioorg Med Chem Lett; 2010 Nov; 20(22):6735-8. PubMed ID: 20850972
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydroquinoline derivatives as opioid receptor antagonists.
Zhang C; Westaway SM; Speake JD; Bishop MJ; Goetz AS; Carballo LH; Hu M; Epperly AH
Bioorg Med Chem Lett; 2011 Jan; 21(2):670-6. PubMed ID: 21193310
[TBL] [Abstract][Full Text] [Related]
15. Novel NK(3) receptor antagonists for the treatment of schizophrenia and other CNS indications.
Simonsen KB; Juhl K; Steiniger-Brach B; Nielsen SM
Curr Opin Drug Discov Devel; 2010 Jul; 13(4):379-88. PubMed ID: 20597024
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 3-aryl-5-acylpiperazinyl-pyrazoles as antagonists to the NK3 receptor.
Hoveyda HR; Roy MO; Blanc S; Noël S; Salvino JM; Ator MA; Fraser G
Bioorg Med Chem Lett; 2011 Apr; 21(7):1991-6. PubMed ID: 21376585
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of new 4-heteroaryl-2-phenylquinolines and their pharmacological activity as NK-2/NK-3 receptor ligands.
Borioni A; Mustazza C; Sestili I; Sbraccia M; Turchetto L; Del Giudice MR
Arch Pharm (Weinheim); 2007 Jan; 340(1):17-25. PubMed ID: 17206605
[TBL] [Abstract][Full Text] [Related]
18. Tetrahydroindolizinone NK1 antagonists.
Bao J; Lu H; Morriello GJ; Carlson EJ; Wheeldon A; Chicchi GG; Kurtz MM; Tsao KL; Zheng S; Tong X; Mills SG; DeVita RJ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2354-8. PubMed ID: 20188553
[TBL] [Abstract][Full Text] [Related]
19. Use of the beta-imager for rapid ex vivo autoradiography exemplified with central nervous system penetrating neurokinin 3 antagonists.
Langlois X; te Riele P; Wintmolders C; Leysen JE; Jurzak M
J Pharmacol Exp Ther; 2001 Nov; 299(2):712-7. PubMed ID: 11602685
[TBL] [Abstract][Full Text] [Related]
20. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
Nordquist RE; Durkin S; Jacquet A; Spooren W
Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
